亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Pregnancy with retained intrauterine device: national-level assessment of characteristics and outcomes

医学 怀孕 优势比 产科 宫内节育器 置信区间 人口 队列研究 计划生育 内科学 环境卫生 遗传学 研究方法 生物
作者
Viraj R. Panchal,Alesandra R. Rau,Rachel S. Mandelbaum,Caroline J. Violette,Clair Harris,Doerthe Brueggmann,Shinya Matsuzaki,Joseph G. Ouzounian,Koji Matsuo
出处
期刊:American Journal Of Obstetrics & Gynecology Mfm [Elsevier BV]
卷期号:5 (9): 101056-101056 被引量:1
标识
DOI:10.1016/j.ajogmf.2023.101056
摘要

BACKGROUND Although intrauterine devices provide effective contraceptive protection, unintentional pregnancy can occur. Previous studies have shown that a retained intrauterine device during pregnancy is associated with adverse pregnancy outcomes but there is a paucity of nationwide data and analysis. OBJECTIVE This study aimed to describe characteristics and outcomes of pregnancies with a retained intrauterine device. STUDY DESIGN This serial cross-sectional study used data from the Healthcare Cost and Utilization Project's National Inpatient Sample. The study population comprised 18,067,310 hospital deliveries for national estimates from January 2016 to December 2020. The exposure was retained intrauterine device status, identified by the World Health Organization's International Classification of Diseases, Tenth Revision, code O26.3. The co-primary outcome measures were incidence rate, clinical and pregnancy characteristics, and delivery outcome of patients with a retained intrauterine device. To assess the pregnancy characteristics and delivery outcomes, an inverse probability of treatment weighting cohort was created to mitigate the prepregnant confounders for a retain intrauterine device. RESULTS A retained intrauterine device was reported in 1 in 8307 hospital deliveries (12.0 per 100,000). In a multivariable analysis, Hispanic individuals, grand multiparity, obesity, alcohol use, and a previous uterine scar were patient characteristics associated with a retained intrauterine device (all P<.05). Current pregnancy characteristics associated with a retained intrauterine device included preterm premature rupture of membrane (9.2% vs 2.7%; adjusted odds ratio, 3.15; 95% confidence interval, 2.41–4.12), fetal malpresentation (10.9% vs 7.2%; adjusted odds ratio, 1.47; 95% confidence interval, 1.15–1.88), fetal anomaly (2.2% vs 1.1%; adjusted odds ratio, 1.71; 95% confidence interval, 1.03–2.85), intrauterine fetal demise (2.6% vs 0.8%; adjusted odds ratio, 2.21; 95% confidence interval, 1.37–3.57), placenta malformation (1.8% vs 0.8%; adjusted odds ratio, 2.12; 95% confidence interval, 1.20–3.76), placenta abruption (4.7% vs 1.1%; adjusted odds ratio, 3.24; 95% confidence interval, 2.25–4.66), and placenta accreta spectrum (0.7% vs 0.1%; adjusted odds ratio, 4.82; 95% confidence interval, 1.99–11.65). Delivery characteristics associated with a retained intrauterine device included previable loss at <22 weeks’ gestation (3.4% vs 0.3%; adjusted odds ratio, 5.49; 95% confidence interval, 3.30–9.15) and periviable delivery at 22 to 25 weeks’ gestation (3.1% vs 0.5%; adjusted odds ratio, 2.81; 95% confidence interval, 1.63–4.86). Patients in the retained intrauterine device group were more likely to have a diagnosis of retained placenta at delivery (2.5% vs 0.4%; adjusted odds ratio, 4.45; 95% confidence interval, 2.70–7.36) and to undergo manual placental removal (3.2% vs 0.6%; adjusted odds ratio, 4.81; 95% confidence interval, 3.11–7.44). CONCLUSION This nationwide analysis confirmed that pregnancy with a retained intrauterine device is uncommon, but these pregnancies may be associated with high-risk pregnancy characteristics and outcomes. Although intrauterine devices provide effective contraceptive protection, unintentional pregnancy can occur. Previous studies have shown that a retained intrauterine device during pregnancy is associated with adverse pregnancy outcomes but there is a paucity of nationwide data and analysis. This study aimed to describe characteristics and outcomes of pregnancies with a retained intrauterine device. This serial cross-sectional study used data from the Healthcare Cost and Utilization Project's National Inpatient Sample. The study population comprised 18,067,310 hospital deliveries for national estimates from January 2016 to December 2020. The exposure was retained intrauterine device status, identified by the World Health Organization's International Classification of Diseases, Tenth Revision, code O26.3. The co-primary outcome measures were incidence rate, clinical and pregnancy characteristics, and delivery outcome of patients with a retained intrauterine device. To assess the pregnancy characteristics and delivery outcomes, an inverse probability of treatment weighting cohort was created to mitigate the prepregnant confounders for a retain intrauterine device. A retained intrauterine device was reported in 1 in 8307 hospital deliveries (12.0 per 100,000). In a multivariable analysis, Hispanic individuals, grand multiparity, obesity, alcohol use, and a previous uterine scar were patient characteristics associated with a retained intrauterine device (all P<.05). Current pregnancy characteristics associated with a retained intrauterine device included preterm premature rupture of membrane (9.2% vs 2.7%; adjusted odds ratio, 3.15; 95% confidence interval, 2.41–4.12), fetal malpresentation (10.9% vs 7.2%; adjusted odds ratio, 1.47; 95% confidence interval, 1.15–1.88), fetal anomaly (2.2% vs 1.1%; adjusted odds ratio, 1.71; 95% confidence interval, 1.03–2.85), intrauterine fetal demise (2.6% vs 0.8%; adjusted odds ratio, 2.21; 95% confidence interval, 1.37–3.57), placenta malformation (1.8% vs 0.8%; adjusted odds ratio, 2.12; 95% confidence interval, 1.20–3.76), placenta abruption (4.7% vs 1.1%; adjusted odds ratio, 3.24; 95% confidence interval, 2.25–4.66), and placenta accreta spectrum (0.7% vs 0.1%; adjusted odds ratio, 4.82; 95% confidence interval, 1.99–11.65). Delivery characteristics associated with a retained intrauterine device included previable loss at <22 weeks’ gestation (3.4% vs 0.3%; adjusted odds ratio, 5.49; 95% confidence interval, 3.30–9.15) and periviable delivery at 22 to 25 weeks’ gestation (3.1% vs 0.5%; adjusted odds ratio, 2.81; 95% confidence interval, 1.63–4.86). Patients in the retained intrauterine device group were more likely to have a diagnosis of retained placenta at delivery (2.5% vs 0.4%; adjusted odds ratio, 4.45; 95% confidence interval, 2.70–7.36) and to undergo manual placental removal (3.2% vs 0.6%; adjusted odds ratio, 4.81; 95% confidence interval, 3.11–7.44). This nationwide analysis confirmed that pregnancy with a retained intrauterine device is uncommon, but these pregnancies may be associated with high-risk pregnancy characteristics and outcomes.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
2秒前
8秒前
energyharvester完成签到 ,获得积分10
10秒前
bxb完成签到,获得积分10
16秒前
Shrine发布了新的文献求助10
18秒前
zqq完成签到,获得积分0
19秒前
万能图书馆应助更明采纳,获得10
21秒前
爆米花应助能干的人采纳,获得50
22秒前
36秒前
量子星尘发布了新的文献求助10
44秒前
葛力发布了新的文献求助10
1分钟前
1分钟前
1分钟前
郭志晟完成签到 ,获得积分10
1分钟前
YY发布了新的文献求助10
1分钟前
能干的人发布了新的文献求助50
1分钟前
传奇3应助科研通管家采纳,获得10
1分钟前
爆米花应助科研通管家采纳,获得10
1分钟前
英姑应助科研通管家采纳,获得10
1分钟前
1分钟前
羽羽完成签到 ,获得积分10
1分钟前
1分钟前
flywire发布了新的文献求助200
1分钟前
lei发布了新的文献求助10
1分钟前
1分钟前
Shrine完成签到,获得积分10
1分钟前
Friday完成签到,获得积分10
1分钟前
开心寄松发布了新的文献求助10
1分钟前
xx关闭了xx文献求助
1分钟前
葛力发布了新的文献求助10
2分钟前
两个轮完成签到 ,获得积分10
2分钟前
量子星尘发布了新的文献求助10
2分钟前
2分钟前
2分钟前
更明发布了新的文献求助10
2分钟前
清爽冬莲完成签到 ,获得积分10
2分钟前
flywire完成签到,获得积分10
2分钟前
葛力发布了新的文献求助10
3分钟前
李爱国应助科研通管家采纳,获得10
3分钟前
cc应助科研通管家采纳,获得10
3分钟前
高分求助中
The Mother of All Tableaux Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 2400
Ophthalmic Equipment Market by Devices(surgical: vitreorentinal,IOLs,OVDs,contact lens,RGP lens,backflush,diagnostic&monitoring:OCT,actorefractor,keratometer,tonometer,ophthalmoscpe,OVD), End User,Buying Criteria-Global Forecast to2029 2000
A new approach to the extrapolation of accelerated life test data 1000
Cognitive Neuroscience: The Biology of the Mind (Sixth Edition) 1000
Optimal Transport: A Comprehensive Introduction to Modeling, Analysis, Simulation, Applications 800
Official Methods of Analysis of AOAC INTERNATIONAL 600
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 588
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3960064
求助须知:如何正确求助?哪些是违规求助? 3506271
关于积分的说明 11128598
捐赠科研通 3238264
什么是DOI,文献DOI怎么找? 1789651
邀请新用户注册赠送积分活动 871846
科研通“疑难数据库(出版商)”最低求助积分说明 803069